Oxygenta Pharma

{
  "main_header": {
    "sid": 798135,
    "name": "Oxygenta Pharma",
    "stock_name": "Oxygenta Pharma",
    "full_name": "Oxygenta Pharmaceutical Ltd",
    "name_url": "stocks-analysis/oxygenta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "48.37",
    "chg": 1.71,
    "chgp": "3.66%",
    "dir": 1,
    "prev_price": "46.66",
    "mcapval": "171.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524636,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE102E01018",
    "curr_date": "Mar 30",
    "curr_time": "",
    "bse_nse_vol": "5.55 k",
    "exc_status": "Active",
    "traded_date": "Mar 30, 2026",
    "traded_date_str": "2026 03 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/oxygenta-pharma-798135-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Markets Rally, But Oxygenta Pharmaceutical Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3924463",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_priceRelatedfactors_3924463.png",
        "date": "2026-03-30 11:19:08",
        "description": ""
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3909790",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_mojoScore_3909790.png",
        "date": "2026-03-24 10:10:16",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3886687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_mojoScore_3886687.png",
        "date": "2026-03-12 10:10:18",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-stock-falls-to-52-week-low-of-rs46-3869473",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_priceRelatedfactors_3869473.png",
        "date": "2026-03-04 11:28:43",
        "description": "Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 on 4 March 2026, marking a significant downturn amid a challenging year for the company. This latest low reflects ongoing pressures on the stock, which has underperformed the broader market and its sector over the past twelve months."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-stock-falls-to-52-week-low-of-rs46-3869475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/OxygentaPharmac_priceRelatedfactors_3869475.png",
        "date": "2026-03-04 11:28:34",
        "description": "Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 today, marking a significant downturn in the stock’s performance amid broader market fluctuations and company-specific concerns."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3862142",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OxygentaPharmac_mojoScore_3862142.png",
        "date": "2026-02-28 10:10:14",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3844240",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OxygentaPharmac_mojoScore_3844240.png",
        "date": "2026-02-17 10:10:20",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/oxygenta-pharmaceutical-ltd-falls-to-52-week-low-amidst-continued-downtrend-3837757",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OxygentaPharmac_priceRelatedfactors_3837757.png",
        "date": "2026-02-13 15:10:47",
        "description": "Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46.6 today, marking a significant downturn amid broader market weakness and company-specific headwinds. The stock’s performance continues to trail the sector and benchmark indices, reflecting ongoing concerns about its financial health and market positioning."
      },
      {
        "title": "Oxygenta Pharmaceutical Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/oxygenta-pharmaceutical-ltd-is-rated-strong-sell-3824182",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/OxygentaPharmac_mojoScore_3824182.png",
        "date": "2026-02-06 10:10:03",
        "description": "Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 February 2026, providing investors with the most recent insights into the company’s performance and outlook."
      }
    ],
    "total": 223,
    "sid": "798135",
    "stock_news_url": "https://www.marketsmojo.com/news/oxygenta-pharmaceutical-798135"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Closure of Trading Window for the period ending on 31.03.2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "20-Feb-2026",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligations and Discloure Requirements) Regulations 2015.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "14-Feb-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Virupaksha Organics Ltd",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Markets Rally, But Oxygenta Pharmaceutical Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-30 11:19:08

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-03-24 10:10:16

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-03-12 10:10:18

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 12 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46

2026-03-04 11:28:43

Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 on 4 March 2026, marking a significant downturn amid a challenging year for the company. This latest low reflects ongoing pressures on the stock, which has underperformed the broader market and its sector over the past twelve months.

Read full news article

Oxygenta Pharmaceutical Ltd Stock Falls to 52-Week Low of Rs.46

2026-03-04 11:28:34

Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46 today, marking a significant downturn in the stock’s performance amid broader market fluctuations and company-specific concerns.

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-02-28 10:10:14

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-02-17 10:10:20

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Oxygenta Pharmaceutical Ltd Falls to 52-Week Low Amidst Continued Downtrend

2026-02-13 15:10:47

Oxygenta Pharmaceutical Ltd’s shares declined sharply to a new 52-week low of Rs.46.6 today, marking a significant downturn amid broader market weakness and company-specific headwinds. The stock’s performance continues to trail the sector and benchmark indices, reflecting ongoing concerns about its financial health and market positioning.

Read full news article

Oxygenta Pharmaceutical Ltd is Rated Strong Sell

2026-02-06 10:10:03

Oxygenta Pharmaceutical Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 February 2026, providing investors with the most recent insights into the company’s performance and outlook.

Read full news article

View All News